Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 28, 2025 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from______to______ Commission file number 001-41069 SWEETGREEN, INC. (Exact name of registrant as specified in its charter) Delaware 27-11592 ...

Market Demand and Growth - AEye anticipates significant growth in demand for its Intelligent Sensing Platform across Automotive and Non-Automotive markets, with a focus on advanced driver-assistance systems and autonomous driving [100]. - The partnership with LITEON aims to produce up to 60,000 units annually for the Apollo product, reflecting a strategic move to meet increasing customer demand [102]. - AEye's collaboration with Accelight Technologies and LighTekton provides access to a potential $2.5 billion market opportunity in China [103]. - The integration of AEye's lidar technology into Nvidia's DRIVE AGX Orin platform is expected to enhance engagement with global automotive OEMs and Tier 1 suppliers [105]. - AEye has seen renewed interest in Apollo from Non-Automotive customers, indicating potential for shorter cycle times and gradual revenue contributions [116]. - The company emphasizes the importance of maintaining technology leadership and responding to evolving customer requirements to secure its market position [113]. Financial Performance - Revenue decreased by $54, or 52%, to $50 for the three months ended September 30, 2025, compared to $104 for the same period in 2024 [126]. - Total revenue decreased by $20, or 13%, to $136 for the nine months ended September 30, 2025, from $156 for the same period in 2024 [138]. - Net loss increased by $624, or 7%, to $9,330 for the three months ended September 30, 2025, from $8,706 for the same period in 2024 [136]. - Net loss decreased by $296, or 1%, to $26,616 for the nine months ended September 30, 2025, from $26,912 for the same period in 2024 [147]. Cost and Expenses - Cost of revenue decreased by $203, or 66%, to $103 for the three months ended September 30, 2025, from $306 for the same period in 2024 [128]. - Cost of revenue decreased by $422, or 58%, to $307 for the nine months ended September 30, 2025, from $729 for the same period in 2024 [139]. - Research and development expenses decreased by $706, or 19%, to $3,061 for the three months ended September 30, 2025, from $3,767 for the same period in 2024 [129]. - Sales and marketing expenses increased by $557, to $631 for the three months ended September 30, 2025, from $74 for the same period in 2024 [130]. Capital and Financing - The company has raised up to $200,000 in capital through a Shelf Registration effective September 26, 2023, with limitations under "baby shelf" rules [151]. - On May 29, 2024, the company completed a Registered Direct Offering, issuing 727,706 shares at a price of $3.448, generating gross proceeds of approximately $2,509 [153]. - The company entered into a Stock Purchase Agreement with New Circle, allowing the sale of up to $50,000 of common stock, with 8,980,713 shares issued for gross proceeds of $27,754 as of September 30, 2025 [154]. - The company has raised additional capital of $9,768 through the sale of 3,164,545 shares under the A.G.P. Agreement after September 30, 2025 [155]. Cash Flow and Liquidity - For the nine months ended September 30, 2025, net cash used in operating activities was $20,247, while net cash provided by financing activities was $82,183 [160][165]. - The company had cash, cash equivalents, and marketable securities totaling $84,333 as of September 30, 2025, indicating a focus on capital preservation and liquidity [174]. Risks and Future Outlook - The company has not engaged in foreign currency exchange hedging activities and does not expect to do so in the foreseeable future, exposing it to potential exchange rate risks [177]. - The company expects to continue needing additional capital resources to fund operations, as expenses are anticipated to exceed operating income [159].

(Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED September 30, 2025 OR UNITED STATES SECURITIES AND EXCHANGE COMMISSION ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Washington, D.C. 20549 FORM 10-Q (State or other jurisdiction of incorporation or organization) Prosperity Bank Plaza 4295 San Felipe, Houston, Texas 77027 (Address of principal executive offices) (Zip Code) TEXAS 74-2 ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (MARK ONE) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarter ended September 30, 2025 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 1-42521 ARTIUS II ACQUISITION INC. (Exact Name of Registrant as Specified in Its Charter) Cayman Islands 98-1802901 (State or other jurisdi ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (MARK ONE) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarter ended September 30, 2025 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 1-42521 ARTIUS II ACQUISITION INC. (Exact Name of Registrant as Specified in Its Charter) Cayman Islands 98-1802901 (State or other jurisdi ...

Exhibit 2.1 EXECUTION VERSION AGREEMENT AND PLAN OF MERGER by and among AQUARIAN HOLDINGS VI L.P., AQUARIAN BEACON MERGER SUB INC., AQUARIAN HOLDINGS LLC (solely for purposes of Section 5.7, Section 6.18, Section 6.19 and Section 9.13) and BRIGHTHOUSE FINANCIAL, INC. Dated as of November 6, 2025 Article I DEFINITIONS 2 Article II THE MERGER 21 Article III EXCHANGE OF SHARES 26 Article IV REPRESENTATIONS AND WARRANTIES OF THE COMPANY 28 i Page Section 1.1 Definitions 2 Section 1.2 Other Definitional and Inte ...

by and among Exhibit 2.1 AQUARIAN HOLDINGS LLC (solely for purposes of Section 5.7, Section 6.18, Section 6.19 and Section 9.13) EXECUTION VERSION and AGREEMENT AND PLAN OF MERGER BRIGHTHOUSE FINANCIAL, INC. AQUARIAN HOLDINGS VI L.P., AQUARIAN BEACON MERGER SUB INC., Dated as of November 6, 2025 Article I DEFINITIONS 2 Article II THE MERGER 21 Article III EXCHANGE OF SHARES 26 Article IV REPRESENTATIONS AND WARRANTIES OF THE COMPANY 28 i Page Section 1.1 Definitions 2 Section 1.2 Other Definitional and Inte ...

Exhibit 2.1 EXECUTION VERSION AGREEMENT AND PLAN OF MERGER by and among AQUARIAN HOLDINGS VI L.P., AQUARIAN BEACON MERGER SUB INC., AQUARIAN HOLDINGS LLC (solely for purposes of Section 5.7, Section 6.18, Section 6.19 and Section 9.13) and BRIGHTHOUSE FINANCIAL, INC. Dated as of November 6, 2025 Article I DEFINITIONS 2 Article II THE MERGER 21 Section 2.1 The Merger 21 Section 2.2 Closing 21 Section 2.3 Certificate of Incorporation and Bylaws of the Surviving Corporation 21 Section 2.4 Directors and Officer ...

Financial Performance - Total revenues for the three months ended September 30, 2025, increased to $13,380,685, up from $12,654,396 in the same period of 2024, representing a growth of 5.7%[17] - Net income for the three months ended September 30, 2025, was $855,009, compared to a net loss of $3,165,139 for the same period in 2024, indicating a significant turnaround[17] - The company reported a basic net income per share from continuing operations of $0.02 for the three months ended September 30, 2025, compared to a loss of $0.03 per share in the same period of 2024[17] - Net income for the nine months ended September 30, 2025, was $1,916,168, a significant improvement compared to a net loss of $(5,814,558) in the same period of 2024[22] - The company reported net cash paid for interest of $37,917 for the nine months ended September 30, 2025, down from $56,668 in 2024[24] - The Franchise Operations segment had a net income of $290,370 for the three months ended September 30, 2025, compared to a loss of $414,383 in the same period of 2024[129] Assets and Liabilities - Total current assets decreased from $74,577,448 as of December 31, 2024, to $60,502,361 as of September 30, 2025, representing a decline of approximately 18.9%[14] - Total liabilities decreased from $62,476,289 to $46,663,932, a reduction of approximately 25.4%[14] - Cash, cash equivalents, and restricted cash increased to $30,713,135 as of September 30, 2025, up from $21,995,436 in 2024[23] - The balance of accounts receivable as of September 30, 2025, was $2,901,028, reflecting a net increase of $2,525,927 during the nine months ended September 30, 2025[79] - As of September 30, 2025, the total liabilities from discontinued operations were $22,878,807, a decrease from $37,367,459 at the end of 2024[85] Cash Flow and Investments - Cash flows from operating activities resulted in a net cash used of $(1,058,973) for the nine months ended September 30, 2025, compared to net cash provided of $5,284,936 in 2024[22] - The company generated $7,778,287 from the sale of clinics during the nine months ended September 30, 2025, compared to $374,100 in 2024[22] - Cash equivalents as of September 30, 2025, had an approximate fair value of $19.1 million, determined using Level 1 inputs[93] - The Company had an allowance for credit losses of $0.3 million as of September 30, 2025, up from $0.2 million as of December 31, 2024, reflecting an increase in expected uncollectible amounts[39] Operational Highlights - The company plans to continue its rapid expansion of chiropractic clinics, focusing on franchising in key North American markets and potentially abroad[9] - The company aims to leverage its regional developer program to accelerate clinic openings across the country[9] - The company expects to continue expanding its franchise operations, as indicated by the 63 executed letters of intent for future clinic licenses[71] - The company opened 21 franchised clinics during the nine months ended September 30, 2025, compared to 46 in the same period of 2024[32] - The company has initiated a refranchising plan for its corporate clinic segment, which is expected to significantly impact operations and financial results[82] Revenue Streams - Franchise fees increased to $964,796 for the three months ended September 30, 2025, compared to $697,688 in 2024, reflecting a growth of 38.3%[17] - Advertising fund revenue rose to $2,344,833 for the three months ended September 30, 2025, compared to $2,247,663 in 2024, marking an increase of 4.3%[17] - Revenues from company-owned or managed clinics for the nine months ended September 30, 2025, were $44,068,960, a decrease of 16.5% from $52,732,070 in the same period of 2024[85] - The company recognized advertising fees received under franchise agreements as advertising fund revenue, contributing to overall revenue growth[74] Challenges and Risks - The nationwide labor shortage has negatively impacted recruitment efforts, which may limit growth strategies and reduce net revenues[10] - The company expects to utilize cash resources to support business operations amid a volatile macroeconomic environment in 2025[10] - The company recorded a loss on disposal of $3,746,449 for the nine months ended September 30, 2025, compared to a loss of $5,598,123 in 2024[86] Future Outlook - The anticipated closing of the Elite Chiro Group Transaction is expected on or before November 25, 2025[10] - The company plans to adopt ASU 2023-09 for the year ending December 31, 2025, which will enhance income tax disclosures[68] - Estimated future revenues from unsatisfied performance obligations total $13,811,047, with $639,221 expected to be recognized in 2025 and $2,504,387 in 2026[81]

Revenue Performance - For the three months ended September 30, 2025, total revenues decreased by 27.3% to $59.19 million from $81.44 million in the same period of 2024[128]. - For the nine months ended September 30, 2025, total revenue decreased by 30.1% to $154.3 million from $220.6 million in the same period in 2024[143]. - The India Biodiesel segment's revenue fell by 55.1% to $14.47 million from $32.26 million, with biodiesel sales volume dropping from 26.0 thousand metric tons to 12.5 thousand metric tons[128][130]. - India Biodiesel segment revenue fell by 67.6% to $29.1 million compared to $89.8 million in the prior year, primarily due to delays in issuing tenders and a shift to fixed price contracts[145]. - The California Ethanol segment generated $40.73 million in revenue, a 9.4% decrease from $44.93 million in 2024, with ethanol sales volume down by 5%[128]. Profitability - Gross profit for the California Ethanol segment turned negative at $(1.43) million, a significant decline from a profit of $0.085 million in 2024[138]. - The California Dairy Renewable Natural Gas segment's gross profit decreased by 31.5% to $1.30 million due to increased costs associated with additional digesters[138]. - Gross profit for the India Biodiesel segment turned negative at $(777,000) for the nine months ended September 30, 2025, compared to a profit of $6.98 million in 2024, reflecting reduced sales and a 51% increase in feedstock costs[151]. Costs and Expenses - Cost of goods sold for the California Ethanol segment decreased by 6.0% to $42.16 million, primarily due to a planned reduction in corn ground[135]. - Total cost of goods sold decreased by 25.7% to $162.8 million for the nine months ended September 30, 2025, from $219.2 million in 2024, driven by reduced sales volumes[146]. - Selling, general and administrative (SG&A) expenses as a percentage of revenue increased to 17% in the nine months ended September 30, 2025, from 13% in the same period in 2024[152]. - Interest expense increased by 17.4% to $34.1 million in the nine months ended September 30, 2025, compared to $29.1 million in 2024, due to higher variable interest rates and debt balances[152]. Cash Flow and Financing - Cash and cash equivalents rose to $5.6 million as of September 30, 2025, compared to $0.9 million at the end of 2024[155]. - Cash used in operating activities was $2.5 million, derived from a net loss of $71.7 million and changes in operating assets and liabilities of $45.8 million[163]. - Cash provided by financing activities was $16.4 million, primarily from $29.2 million in borrowings and $25.7 million from sales of common stock[165]. - During the nine months ended September 30, 2025, the company sold 13 million shares of common stock for net proceeds of $25.5 million[166]. - The outstanding balance of senior secured debt as of September 30, 2025, totaled $236.6 million, with future amendments to debt facilities subject to lender discretion[159]. - Total increases to debt amounted to $67.362 million, while total decreases to debt were $51.920 million, resulting in a net change in total debt of $15.442 million[160]. Operational Developments - The company is developing a SAF/RD production plant with a capacity of 90 million gallons per year, with significant progress in obtaining necessary permits[123]. - Planned CCUS projects aim to capture and sequester over two million metric tons of CO₂ per year, generating revenue from California LCFS credits and federal tax credits[124]. - The company is actively expanding its biogas collection pipeline, with 36 miles constructed and environmental approval for an additional 24 miles[119]. - The California Dairy Renewable Natural Gas segment sold 291.3 thousand MMBtu of RNG at an average price of $3.24 per MMBtu, up from $2.88 per MMBtu in the prior year[144]. Stock and Market Activity - The company has ongoing at-the-market stock sales registration allowing for continuous share sales into the market[166]. - There were no off-balance sheet arrangements reported[169].